UBS Downgrades Allstate to Neutral, Raises Price Target to $261

Benzinga Newsdesk www.benzinga.com Negative 46.5%

Neg 46.5% Neu 0% Pos 0%

UBS analyst Brian Meredith downgrades Allstate (NYSE:ALL) from Buy to Neutral and raises the price target from $255 to $261.